Literature DB >> 20217466

Cardiac resynchronization therapy in patients undergoing open-chest cardiac surgery.

Alberto Barosi1, Maurizio Lunati, Giancarlo Speca, Alessandro Mazzola, Gabriele Paglino, Michele De Bonis, Saverio Iacopino, Mauro Cassese, Cosimo Damiano Dicandia, Giampiero Esposito, Marco Vimercati, Alberto Della Scala, Ettore Vitali.   

Abstract

PURPOSE: Few data are available on the effects of cardiac resynchronization therapy (CRT) in candidates for cardiac surgery and affected by severe heart failure (HF). The aim of our analysis is to evaluate the percentage of patients who maintain indication for CRT after surgery and the efficacy of CRT in those patients subsequently implanted.
METHODS: We enrolled 124 HF patients with indication both to heart surgery and to CRT. During surgery, an epicardial left ventricular lead was implanted, tunneled to a subclavear pocket, and capped. Afterward, patients were periodically reassessed to confirm indication for CRT.
RESULTS: CRT indication was confirmed within 1 month from surgery in 54 patients (group A) and in 33 patients within 6 months (group B). In group A and B, 63% and 71% of patients were considered responders according to an arbitrary five-point increase of left ventricular ejection fraction (LVEF), respectively. The assessment of clinical response at 1 year, based on the definitions proposed by Packer, identified 63% and 80% of responders in group A and B, respectively.
CONCLUSIONS: Our data show that a remarkable percentage of patients maintain an indication for CRT after cardiac surgery (76%), while in the remaining 24% the lack of an indication is confirmed by a higher LVEF at last follow-up. In combination with surgery, CRT proved to be an effective therapy in those patients who were subsequently implanted. The suggested method is simple, without significant adjunctive risks, and allows easier CRT implantation with stable thresholds.

Entities:  

Mesh:

Year:  2010        PMID: 20217466     DOI: 10.1007/s10840-009-9451-2

Source DB:  PubMed          Journal:  J Interv Card Electrophysiol        ISSN: 1383-875X            Impact factor:   1.900


  21 in total

1.  Limited thoracotomy as a second choice alternative to transvenous implant for cardiac resynchronisation therapy delivery.

Authors:  Andrea Puglisi; Maurizio Lunati; Antonino G M Marullo; Stefano Bianchi; Mariano Feccia; Fabrizio Sgreccia; Ilaria Vicini; Sergio Valsecchi; Francesco Musumeci; Ettore Vitali
Journal:  Eur Heart J       Date:  2004-06       Impact factor: 29.983

2.  Perioperative biventricular pacing leads to improvement of hemodynamics in patients with reduced left-ventricular function--interim results.

Authors:  Omer Dzemali; Farhad Bakhtiary; Selami Dogan; Thomas Wittlinger; Anton Moritz; Peter Kleine
Journal:  Pacing Clin Electrophysiol       Date:  2006-12       Impact factor: 1.976

Review 3.  ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM).

Authors:  Kenneth Dickstein; Alain Cohen-Solal; Gerasimos Filippatos; John J V McMurray; Piotr Ponikowski; Philip Alexander Poole-Wilson; Anna Strömberg; Dirk J van Veldhuisen; Dan Atar; Arno W Hoes; Andre Keren; Alexandre Mebazaa; Markku Nieminen; Silvia Giuliana Priori; Karl Swedberg
Journal:  Eur J Heart Fail       Date:  2008-09-16       Impact factor: 15.534

4.  Left ventricular reverse remodeling but not clinical improvement predicts long-term survival after cardiac resynchronization therapy.

Authors:  Cheuk-Man Yu; Gabe B Bleeker; Jeffrey Wing-Hong Fung; Martin J Schalij; Qing Zhang; Ernst E van der Wall; Yat-Sun Chan; Shun-Ling Kong; Jeroen J Bax
Journal:  Circulation       Date:  2005-09-06       Impact factor: 29.690

5.  Temporary left ventricular pacing improves haemodynamic performance in patients requiring epicardial pacing post cardiac surgery.

Authors:  Michael J Flynn; Janet M McComb; John Henry Dark
Journal:  Eur J Cardiothorac Surg       Date:  2005-08       Impact factor: 4.191

Review 6.  The problem of non-response to cardiac resynchronization therapy.

Authors:  David H Birnie; Anthony Sl Tang
Journal:  Curr Opin Cardiol       Date:  2006-01       Impact factor: 2.161

7.  The effect of cardiac resynchronization on morbidity and mortality in heart failure.

Authors:  John G F Cleland; Jean-Claude Daubert; Erland Erdmann; Nick Freemantle; Daniel Gras; Lukas Kappenberger; Luigi Tavazzi
Journal:  N Engl J Med       Date:  2005-03-07       Impact factor: 91.245

Review 8.  Efficacy of prophylactic epicardial pacing leads in children and young adults.

Authors:  Mitchell I Cohen; Larry A Rhodes; Thomas L Spray; J William Gaynor
Journal:  Ann Thorac Surg       Date:  2004-07       Impact factor: 4.330

9.  Cardiac resynchronization therapy as an adjunct to conventional surgical treatment for heart failure.

Authors:  Ugo F Tesler; Guido Lanzillo; Eugenio Novelli; Gheorge Cerin; Marco Diena
Journal:  Tex Heart Inst J       Date:  2008

10.  Do abandoned leads pose risk to implantable cardioverter-defibrillator patients?

Authors:  Michael Glikson; Mahmoud Suleiman; David M Luria; Marjorie L Martin; David O Hodge; Win-Kuang Shen; David J Bradley; Thomas M Munger; Robert F Rea; David L Hayes; Stephen C Hammill; Paul A Friedman
Journal:  Heart Rhythm       Date:  2008-10-11       Impact factor: 6.343

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.